Racial Disparity in CSF Amyloid and Tau Biomarkers in Mild Cognitive Impairment
This case-control study compares cerebrospinal fluid (CSF) amyloid and tau biomarkers for Alzheimer disease in African American and white individuals with normal cognition and with mild cognitive impairment.